Emergent BioSolutions (EBS) Tops Q4 EPS by 19c
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $7.02 +4.00%
Revenue Growth %: -45.6%
Financial Fact:
Provision for (benefit from) income taxes: 13.17M
Today's EPS Names:
ALZN, ASPU, USAU, More
Revenue Growth %: -45.6%
Financial Fact:
Provision for (benefit from) income taxes: 13.17M
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q4 EPS of $0.67, $0.19 better than the analyst estimate of $0.48. Revenue for the quarter came in at $151.7 million versus the consensus estimate of $120.45 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McDonald’s said to plan value strategy overhaul to revive US sales growth
- UBS Upgrades Kyocera (6971:JP) (KYOCY) to Buy
- UBS sees a negative catalyst ahead for Nike: Here’s what to watch
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
